TipRanks
Heart Test Laboratories, Inc. (HSCS)
NASDAQ:HSCS
US Market
HSCS
Heart Test Laboratories, Inc.
RESEARCH TOOLSreports
Want to see HSCS full AI Analyst Report?

Heart Test Laboratories, Inc. (HSCS) Ratios

219 Followers

Heart Test Laboratories, Inc. Ratios

HSCS's free cash flow for Q1 2027 was $-15.80. For the 2027 fiscal year, HSCS's free cash flow was decreased by $ and operating cash flow was $-1.40K. See a summary of the company’s cash flow.
Ratios
TTM
Apr 26Apr 25Apr 24Apr 23
Liquidity Ratios
Current Ratio
 0.12 0.53 0.59 4.20 1.47
Quick Ratio
 -71.42 0.40 0.41 3.84 1.10
Cash Ratio
 5.31 0.34 0.30 3.32 0.91
Solvency Ratio
 -1.78 >-0.01 -2.15 -2.98 -2.07
Operating Cash Flow Ratio
 -235.10 >-0.01 -2.00 -3.47 -3.15
Short-Term Operating Cash Flow Coverage
 -355.72 >-0.01 -2.91 -12.14 -11.55
Net Current Asset Value
$ -5.08M$ -2.45B$ -1.85M$ 5.17M$ -360.10K
Leverage Ratios
Debt-to-Assets Ratio
 1.07 0.75 0.71 0.11 0.48
Debt-to-Equity Ratio
 -1.97 17.46 14.55 0.14 6.79
Debt-to-Capital Ratio
 2.03 0.95 0.94 0.12 0.87
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.68
Financial Leverage Ratio
 -1.84 23.34 20.58 1.30 14.26
Debt Service Coverage Ratio
 -2.09 >-0.01 -2.70 -7.21 -8.19
Interest Coverage Ratio
 -11.78 -11.17 -16.69 -17.81 -25.14
Debt to Market Cap
 0.40 707.50 0.77 0.15 0.15
Interest Debt Per Share
 1.31 1.50K 3.72 3.94 22.75
Net Debt to EBITDA
 2.73 -270.99 -0.23 0.78 0.02
Profitability Margins
Gross Profit Margin
-2908.83%-2982.15%-2884.71%-444.16%-476.91%
EBIT Margin
-209733.08%-194787.38%-192013.10%-33608.22%-118662.45%
EBITDA Margin
-209669.95%-194787.38%-189071.61%-33096.75%-118139.83%
Operating Profit Margin
-209733.08%-194787.38%-192013.10%-33901.99%-118698.33%
Pretax Profit Margin
-227024.23%-211666.47%-201499.52%-35511.87%-123384.27%
Net Profit Margin
-227024.23%-211666.47%-201499.52%-35511.87%-123384.27%
Continuous Operations Profit Margin
-227024.23%-211666.47%-201499.52%-35511.87%-123384.27%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
108.24%108.67%104.94%104.75%103.95%
Return on Assets (ROA)
-274.52%-0.17%-207.56%-69.51%-193.30%
Return on Equity (ROE)
-816.25%-4.05%-4272.16%-90.27%-2756.06%
Return on Capital Employed (ROCE)
499.92%-2.10%-1607.20%-81.35%-420.33%
Return on Invested Capital (ROIC)
-480.77%-0.20%-261.80%-75.49%-308.13%
Return on Tangible Assets
0.62%-0.32%-336.27%-83.46%-193.30%
Earnings Yield
-65.03%-178.57%-266.15%-202.78%-94.57%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 1.00 0.00 0.00
Payables Turnover
 0.13 <0.01 0.41 0.23 0.05
Inventory Turnover
 <0.01 <0.01 0.20 0.16 0.04
Fixed Asset Turnover
 <0.01 <0.01 <0.01 0.03 <0.01
Asset Turnover
 <0.01 <0.01 <0.01 <0.01 <0.01
Working Capital Turnover Ratio
 >-0.01 >-0.01 <0.01 <0.01 -0.02
Cash Conversion Cycle
 1.08M 924.86K 1.30K 652.71 552.70
Days of Sales Outstanding
 0.00 0.00 365.00 0.00 0.00
Days of Inventory Outstanding
 1.08M 1.80M 1.83K 2.27K 8.31K
Days of Payables Outstanding
 2.75K 872.83K 895.83 1.62K 7.76K
Operating Cycle
 1.08M 1.80M 2.19K 2.27K 8.31K
Cash Flow Ratios
Operating Cash Flow Per Share
 -360.96 -2.83 -7.90 -17.22 -72.62
Free Cash Flow Per Share
 -360.97 -2.85 -7.93 -17.57 -72.85
CapEx Per Share
 0.01 0.02 0.03 0.36 0.23
Free Cash Flow to Operating Cash Flow
 1.00 1.01 1.00 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
 -30.35K -167.07 -245.56 -48.46 -315.36
Capital Expenditure Coverage Ratio
 -30.35K -167.07 -245.56 -48.46 -315.36
Operating Cash Flow Coverage Ratio
 -330.71 >-0.01 -2.48 -5.86 -3.69
Operating Cash Flow to Sales Ratio
 -293.06K -1.72K -1.70K -326.35 -1.12K
Free Cash Flow Yield
-14262.30%-145.93%-226.01%-190.20%-86.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.34 -0.56 -0.38 -0.49 -1.06
Price-to-Sales (P/S) Ratio
 2.05K 1.19K 757.08 175.12 1.30K
Price-to-Book (P/B) Ratio
 -7.76 0.02 16.05 0.45 29.14
Price-to-Free Cash Flow (P/FCF) Ratio
 >-0.01 -0.69 -0.44 -0.53 -1.16
Price-to-Operating Cash Flow Ratio
 -0.01 -0.69 -0.44 -0.54 -1.16
Price-to-Earnings Growth (PEG) Ratio
 -0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
 -7.76 0.02 16.05 0.45 29.14
Enterprise Value Multiple
 1.75 -271.60 -0.63 0.25 -1.09
Enterprise Value
 -16.62M 2.28B 5.18M -1.51M 6.62M
EV to EBITDA
 1.75 -271.60 -0.63 0.25 -1.09
EV to Sales
 -3.68K 529.05K 1.19K -81.40 1.29K
EV to Free Cash Flow
 0.01 -305.84 -0.70 0.24 -1.14
EV to Operating Cash Flow
 0.01 -307.67 -0.70 0.25 -1.15
Tangible Book Value Per Share
 -453.76 -817.51 -1.50 16.25 2.90
Shareholders’ Equity Per Share
 -0.55 85.90 0.22 20.76 2.90
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 <0.01 <0.01 <0.01 0.05 0.06
Net Income Per Share
 -2.80 -3.48 -9.34 -18.74 -79.92
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.08 1.09 1.05 1.06 1.04
Research & Development to Revenue
 200.41K 657.33K 1.01K 154.76 477.84
SG&A to Revenue
 449.87K 1.29M 882.98 0.00 0.00
Stock-Based Compensation to Revenue
 163.76K 303.86 57.44 21.78 48.22
Income Quality
 0.42 0.81 0.85 0.92 0.91
Currency in USD